CIK 0001802768 · Large accelerated filer
Royalty Pharma plc
Sign in to watch- Ticker
- RPRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- (212) 883-0200
- Business address
- 110 EAST 59TH STREET, NEW YORK, NY, 10022
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,324,753
- in 4 filings, $12.3M under 10b5-1 plans
Net −$12,324,753. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-05 | HODGSON DAVID C Director | Grant or award | +4,545 | 37,873 | ||
| 2026-06-05 | LOVE TED W Director | Grant or award | +4,545 | 58,393 | ||
| 2026-06-05 | WEATHERMAN ELIZABETH H Director | Grant or award | +4,545 | 13,103 | ||
| 2026-05-26 | Coyne Terrance P. EVP & CFO | Sale 10b5-1 | −64,399 | $53.98 | $3.5M | 0 |
| 2026-05-20 | Urist Marshall EVP, Research & Investments | Sale 10b5-1 | −13,684 | $52.75 | $722K | 18,197 |
| 2026-05-14 | Urist Marshall EVP, Research & Investments | Sale 10b5-1 | −13,684 | $53.06 | $726K | 31,881 |
| 2026-05-14 | Norden Gregory Director | Sale 10b5-1 | −3,045 | $53.00 | $161K | 191,803 |
| 2026-05-06 | Urist Marshall EVP, Research & Investments | Grant or award | +18,197 | 45,565 | ||
| 2026-05-06 | Coyne Terrance P. EVP & CFO | Grant or award | +24,263 | 64,399 | ||
| 2026-05-06 | Hite Christopher EVP & Vice Chairman | Grant or award | +24,263 | 709,399 | ||
| 2026-05-06 | Legorreta Pablo G. CEO, Chairman of the Board | Grant or award | +143,821 | 1,242,604 | ||
| 2026-04-28 | Coyne Terrance P. EVP & CFO | Sale 10b5-1 | −32,916 | $49.78 | $1.6M | 0 |
| 2026-04-28 | Coyne Terrance P. EVP & CFO | Sale 10b5-1 | −1,875 | $49.78 | $93K | 40,136 |
| 2026-04-01 | Coyne Terrance P. EVP & CFO | Sale 10b5-1 | −1,875 | $48.33 | $91K | 42,011 |
| 2026-04-01 | Coyne Terrance P. EVP & CFO | Sale 10b5-1 | −32,916 | $48.33 | $1.6M | 32,916 |
| 2026-03-31 | Bassler Bonnie L Director | Grant or award | +815 | $45.98 | $37K | 73,947 |
| 2026-03-23 | Coyne Terrance P. EVP & CFO | Sale 10b5-1 | −32,916 | $45.53 | $1.5M | 65,832 |
| 2026-03-23 | Coyne Terrance P. EVP & CFO | Sale 10b5-1 | −1,875 | $45.53 | $85K | 43,886 |
| 2026-03-02 | Coyne Terrance P. EVP & CFO | Sale 10b5-1 | −22,487 | $46.67 | $1.0M | 109,177 |
| 2026-03-02 | Coyne Terrance P. EVP & CFO | Sale 10b5-1 | −10,429 | $47.01 | $490K | 98,748 |
Page 3 of 8 · 159 trades